Specifications
Immunogen
Recombinant fragment corresponding to Human BDNF aa 19-247. Expressed in E. Coli.Sequence: APMKEANIRGQGGLAYPGVRTHGTLESVNGPKAGSRGLTSLADTFEHVIE ELLDEDQKVRPNEENNKDADLYTSRVMLSSQVPLEPPLLFLLEEYKNYLD AANMSMRVRRHSDPARRGELSVCDSISEWVTAADKKTAVDMSGGTVTVLE KVPVSKGQLKQ
Applications
Application Notes
WB: 1/500 - 1/2000; ICC/IF: 1/200 - 1/1000;
Target
Alternative Names
BDNF; brain-derived neurotrophic factor; neurotrophin; abrineurin; MGC34632;
Product Background
Antigen Description
During development, promotes the survival and differentiation of selected neuronal populations of the peripheral and central nervous systems. Participates in axonal growth, pathfinding and in the modulation of dendritic growth and morphology. Major regulator of synaptic transmission and plasticity at adult synapses in many regions of the CNS. The versatility of BDNF is emphasized by its contribution to a range of adaptive neuronal responses including long-term potentiation (LTP), long-term depression (LTD), certain forms of short-term synaptic plasticity, as well as homeostatic regulation of intrinsic neuronal excitability.
Pathway
Cocaine addiction, organism-specific biosystem; Cocaine addiction, conserved biosystem; Huntingtons disease, organism-specific biosystem; Huntingtons disease, conserved biosystem; MAPK signaling pathway, organism-specific biosystem; MAPK signaling pathway, organism-specific biosystem; MAPK signaling pathway, conserved biosystem;
Citations
Publication ()
Have you cited DCABH-7326 in a publication?
Let us know and earn a reward for your research.